Jen, Juif <br/><br/>
Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Oct 2002 
 - 349-61 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1067/mcp.2002.127112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Logistic Models<br/>Male<br/>Models, Biological<br/>Ribavirin--administration & dosage